Cite
Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study.
MLA
Strongman, H., et al. “Comparison of Diabetes-Associated Secondary Healthcare Utilization between Alternative Oral Antihyperglycaemic Dual Therapy Combinations with Metformin in Patients with Type 2 Diabetes: An Observational Cohort Study.” Diabetes, Obesity & Metabolism, vol. 17, no. 6, June 2015, pp. 573–80. EBSCOhost, https://doi.org/10.1111/dom.12458.
APA
Strongman, H., D’Oca, K., Langerman, H., & Das, R. (2015). Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study. Diabetes, Obesity & Metabolism, 17(6), 573–580. https://doi.org/10.1111/dom.12458
Chicago
Strongman, H, K D’Oca, H Langerman, and R Das. 2015. “Comparison of Diabetes-Associated Secondary Healthcare Utilization between Alternative Oral Antihyperglycaemic Dual Therapy Combinations with Metformin in Patients with Type 2 Diabetes: An Observational Cohort Study.” Diabetes, Obesity & Metabolism 17 (6): 573–80. doi:10.1111/dom.12458.